(Q31111151)

28 June 2017

title

Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation (English)

1 reference

28 June 2017

1 reference

Negi AK

1

1 reference

28 June 2017

Vernon SA

series ordinal

2

1 reference

28 June 2017

Lim CS

series ordinal

3

1 reference

28 June 2017

Owen-Armstrong K

series ordinal

4

1 reference

28 June 2017

publication date

1 July 2005

1 reference

28 June 2017

1 reference

28 June 2017

volume

19

1 reference

28 June 2017

issue

7

1 reference

28 June 2017

page(s)

747-751

1 reference

The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

Progressive Enlargement of Laser Scars Following Grid Laser Photocoagulation for Diffuse Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intravitreal triamcinolone for refractory diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Noninfectious endophthalmitis associated with intravitreal triamcinolone injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701636

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701636

1 reference

Dimensions Publication ID

28 June 2017

1050473933

0 references

1 reference